3rd Annual ISCI Hematology and Oncology Update
Conference Overview
Inova Schar Cancer Institute presents:
3rd Annual ISCI Hematology and Oncology Update: A Symposium for Primary Care Physicians & Advanced Practice Providers
This half-day symposium will serve as an update on a range of topics, including lung cancer; immunotherapy side effects and toxicities; HPV head and neck cancer; myeloma and MGUS; lymphoma; women’s malignancies- genetics, screening, and prevention; how to approach an abnormal CBC, when to refer; and understanding the team approach to cancer care for better outcomes.
This symposium's target audience is primary care physicians. Other types of clinicians who may be interested: Oncology Physicians, Hospitalists, Advanced Practice Providers, Researchers, Oncology Nurses, Medical Students.
Program Directors
John Deeken, MD
President, Medical Oncologist
Inova Schar Cancer Institute
Neeta Goel, MD
Chief Medical Officer,
Ambulatory Services
David Heyer, MD
Division Chief,
Hematology/Oncology
Inova Schar Cancer Institute
Learning Objectives
Accreditation
Inova CME Accreditation
The Inova Office of Continuing Medical Education is accredited by the Medical Society of Virginia to sponsor continuing medical education for physicians.
Credit Designation
The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 4.75 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 4.75 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.